Last reviewed · How we verify
NCT04969302
Examination of the Effect of Skin Antisepsis With Pre-heated Povidone Iodine on Surgical Site Infections: A Quasi-Experimental Study
NA trial testing Follow-up in Surgical Site Infections in 124 participants. Completed in 28 July 2022.
28 December 2021
Quick facts
| Lead sponsor | Eastern Mediterranean University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 124 |
| Start date | 28 September 2021 |
| Primary completion | 28 December 2021 |
| Estimated completion | 28 July 2022 |
| Sites | 1 location across Cyprus |
Drugs / interventions tested
- Follow-up
Conditions studied
- Surgical Site Infections — all drugs for Surgical Site Infections →
Sponsor
Eastern Mediterranean University
Who can join
Adults 18 to 60, any sex, with Surgical Site Infections. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Surgical Site Infections (SSI) develop as a complication of surgical care 30-90 days after surgery without implants and within 1 year after implanted operations. Despite advances in asepsis practices, sterilization methods, surgical technique and antibiotic prophylaxis, SSI is the most important cause of hospital stay, morbidity and even mortality. SSI, which constitutes approximately 20% of healthcare associated infections (HAI) all over the world, is also the HAI with the highest cost. Although it has been reported that 60% of the SSI can be prevented by using evidence-based guidelines, 2-5% of the operated patients develop SSI, the hospital stay of patients with SSI is 7-11 days longer, the risk of death increases 2-11 times, It was reported that the cause of death was direct SSI. In the United States of America (USA), SSI constitutes 31% of HAI, it is seen in 2-5% of inpatients, approximately 160,000-300,000 SSIs occur each year, the most common and costly HAI.Abdominal surgery; It includes the treatment of diseases of organs such as stomach, gall bladder, pancreas, spleen, liver, small intestine and large intestine. It has been reported that the incidence of SSIs after abdominal surgery is 15-25% higher than other types of surgery. In a study conducted by Alcan et al. (2020), 69.8% of nurses stated that they used Povidone Iodine as skin antisepsis. Wistrand et al. (2015) compared preoperative 36 ° C and room temperature 20 ° C Chlorhexidine Gluconate solutions, but reported that there was no difference in bacterial colonization and SSI rates. In their study in Turkey, Gezer et al. (2020) reported that the prevalence of SSI was significantly lower in the Povidone Iodine group heated to 37 ° C before surgery compared to the Povidone Iodine group applied at 25 ° C room temperature.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Antimicrobial approach of abdominal post-surgical infections.
Fiore M, Corrente A, Di Franco S, Alfieri A, et al · · 2023 · cited 6× · PMID 38222012 · DOI 10.4240/wjgs.v15.i12.2674
Verify or expand the search:
- PubMed search for NCT04969302
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Follow-up
Trials testing the same drug.
- NCT06743282 — Senyo Health With Substance Use Disorder (SUD) in Primary Care · NA · enrolling by invitation
- NCT07007377 — Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients · recruiting
- NCT06866483 — Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-m · recruiting
- NCT06651203 — Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Dise · not yet recruiting
- NCT06381284 — Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients · completed
Other recruiting trials for Surgical Site Infections
Currently open trials in the same condition.
- NCT07189858 — Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections - Canada · NA · active not recruiting
- NCT06603961 — Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages · NA · recruiting
- NCT06780813 — Supplemental High Flow Oxygen to Reduce Infections in Obese Gynecological Cancer Patients · NA · recruiting
- NCT06702878 — Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections · Phase 3 · active not recruiting
- NCT06801275 — The Effect of Number of Showers With 4% Chlorhexidine Gluconate on Prevention of Surgical Site Infections · NA · active not recruiting
Other Eastern Mediterranean University trials
Trials by the same sponsor.
- NCT07462039 — Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing · NA · not yet recruiting
- NCT07328750 — Dynamic Q Angle and Core Endurance in Adolescent Athletes With Patellofemoral Pain Syndrome · recruiting
- NCT07311005 — NURSE - LED DIGITAL EDUCATION AND BIGOREXIA · NA · enrolling by invitation
- NCT07077993 — "Muscle Strength, Balance, and Core Endurance in Elite Adolescent Rowers: A Cross-Sectional Study" · completed
- NCT06953037 — Effects of Acupressure Applied Before Cesarean Delivery on Anxiety, Physiological Parameters and Fetal Heart Rate · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04969302 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Eastern Mediterranean University
- Last refreshed: 19 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04969302.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing